Markets
U.S. close in 4 hrs, 52 mins
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
Chairman of the Board and President Announced to Lead the North Carolina Advanced Medical Technologies Center of Innovation
Business Wire
J. Greg Davis has been elected Chairman of the Board and Cindy Clark has
been appointed President of the North Carolina Advanced Medical
Technologies Center of Innovation (NC AMTC). The NC AMTC is a new
non-profit corporation established to promote the growth of North
Carolina’s advanced medical technologies industry. The NC AMTC has been
awarded a four-year, $2.5 million grant from the North Carolina
Biotechnology Center’s Centers of Innovation Program. The North Carolina
Biosciences Organization (NCBIO) led a statewide effort to establish the
NC AMTC, including the preparation of a preliminary business plan.
“This is the culmination of three years of intensive planning and market
research,” said Sam Taylor, President of NCBIO. “We are delighted to
have Greg’s 22 years of wisdom and guidance leading the board of
directors and Cindy’s exceptional entrepreneurial talents full-time to
promote the growth and development of the advanced medical technologies
industry in North Carolina.”
Greg Davis is an experienced medical device executive with broad global
and functional experience in finance, manufacturing, sales and general
management. Greg is currently the CEO of Tryton Medical, Inc. Prior to
joining Tryton Medical, Greg was president of Guidant Japan. Greg also
managed Guidant’s product portfolio in 13 Asian countries and was
instrumental in the start up and management of an FDA-regulated, Class
III manufacturing facility in Dorado, Puerto Rico. Greg started his
career in various financial management roles with Cardiac Pacemakers
Incorporated and Eli Lilly in the U.S. and Puerto Rico. Greg holds a
bachelors of science in mechanical engineering from the University of
Minnesota and a masters of business administration from the University
of Michigan.
Cindy Clark, J.D., has over 17 years of experience launching and leading
early-stage life science companies. Most recently, she was the CEO of
Sirga Advanced Biopharma, Inc. and NanIO Biosciences, Inc., and she
remains on their boards of directors. She has held senior management
positions at Phase Biosciences, Erimos Pharmaceuticals, MedCases, Bell
Atlantic Internet Solutions, CV Therapeutics, and Univax Biologics (now
NABI). She has a bachelors of arts degree in mathematics and government
from Wesleyan University and a juris doctorate from the Washington
College of Law, American University. “Cindy was selected after an
extensive, nation-wide search for the new Center’s founding president.
The hiring committee was impressed with her entrepreneurial experience
and demonstrated ability to build alliances and deliver results,” states
Greg Davis.
The advanced medical technologies industry, which includes devices,
diagnostics, imaging agents and other medical technologies, is a
burgeoning industry in North Carolina, with over 400 companies in this
sector. “It is an honor to have been chosen to be one of the leading
champions for this industry. I look forward to sharing many exciting
announcements in the coming months as we launch this new organization.
The AMT industry will be a driving force in the North Carolina life
sciences community in the years to come,” states Cindy Clark, the new NC
AMTC president.
The North Carolina Biotechnology Center is a private, non-profit
corporation supported by the N.C. General Assembly. Its mission is to
provide long-term economic and societal benefits to North Carolina by
supporting biotechnology research, business, education and strategic
policy statewide.
NCBIO is the trade association for North Carolina’s life science
industry. Members include companies and research institutions working in
the pharmaceutical, medical device, diagnostic, clinical research and
agricultural biotechnology sectors, as well as firms and non-profits
that provide support services to life science companies. Founded in
1993, NCBIO has been working for more than fifteen years to help the
North Carolina’s life science community fulfill its extraordinary
promise as a source of economic opportunity and improved quality of life.
Copyright Business Wire 2009
2009-11-04 15:12:00
COMMENTS ( 0 )